Insmed Incorporated (INSM) returns

Biotechnology · NASDAQ · Health Care

$112.58 +0.89% Close Oct 30, 2026 Live

Insmed returns over 10 years

$1,000 invested in Insmed ten years ago was worth $8,315 at the close on October 30, 2026, with dividends reinvested: an average return of 23.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

INSM, $10,000 investedS&P 500 (SPY)
$10,000$100,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month -1.4% — $986.33 -0.9%
3 months +10.9% — $1,109 +2.1%
Year to date -35.3% — $646.86 +11.7%
1 year -42.0% — $579.65 +12.4%
3 years +373.0% +67.9% $4,730 +88.5%
5 years +273.4% +30.1% $3,734 +76.0%
10 years +731.5% +23.6% $8,315 +316.6%

Insmed return by calendar year

YearINSMS&P 500 (SPY)Difference
2026 to date -35.3% +11.7% -47.0%
2025 +152.1% +17.7% +134.4%
2024 +122.8% +24.9% +97.9%
2023 +55.1% +26.2% +28.9%
2022 -26.7% -18.2% -8.5%
2021 -18.2% +28.7% -46.9%
2020 +39.4% +18.4% +21.0%
2019 +82.0% +31.2% +50.8%
2018 -57.9% -4.6% -53.4%
2017 +135.7% +21.7% +114.0%
2016 -27.1% +12.0% -39.1%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: INSM financials

No forecast, no recommendation. This page describes Insmed Incorporated from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.